On January 27, 2011, MAPS Clinical Research Associate Berra Yazar-Klosinski, Ph.D., will meet with Kamila Novak, Program Manager of the contract clinical research organization (CRO) Antaea Medical Services, which MAPS has hired to monitor both our Jordanian and Israeli studies. Berra and Kamila will conduct a closeout visit for MAPS’ previous Israeli study of MDMA-assisted psychotherapy for PTSD. An abbreviated report has already been written for submission to the FDA and the Israeli Ministry of Health, and it will be made available on our website after it is submitted. The study was concluded on March 26, 2010, after five subjects were treated.
